Download PDF
Anästhesiol Intensivmed Notfallmed Schmerzther 2014; 49(4): 256-264
DOI: 10.1055/s-0034-1373805
Fachwissen
Intensivmedizin Topthema:
© Georg Thieme Verlag Stuttgart · New York

Patient Blood Management – Der Patient im Krankenhaus

Patient Blood Management – The inpatient care
Dania Fischer
,
Christof Geisen
,
Björn Steffen
,
Patrick Meybohm
,
Thomas Schmitz-Rixen
Further Information

Publication History

Publication Date:
02 May 2014 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Das multimodale Konzept des Patient Blood Managements tangiert zahlreiche Aspekte der Krankenhausbehandlung eines Patienten. Hauptaugenmerk liegt darauf, patienteneigene Ressourcen zu schonen und zu stärken. Dies kann v.a. durch akribische Minimierung des perioperativen Blutverlusts und den Ausbau und die Ausschöpfung der individuellen Anämietoleranz erreicht werden. Blutprodukte sollen erst nach Optimierung aller anderen Aspekte leitliniengerecht zur Anwendung kommen, um die mit allogenen Bluttransfusionen verbundenen Risiken zu vermeiden. Das vorgeschlagene Maßnahmenbündel besitzt großes Potenzial zur Steigerung der Patientensicherheit!

Abstract

The multimodal concept of Patient Blood Management touches many aspects of in-hospital treatment. The goals are to preserve and strengthen the patients' own resources in order to avoid transfusion-associated adverse events. This can be achieved by meticulous minimization of perioperative blood loss and the enhancement and full utilization of individual anaemia tolerance. The transfusion of allogeneic blood products shall be guideline-based only. The proposed package of measures has immense potential to increase patient safety!

Kernaussagen

  • Allogene Bluttransfusionen steigern dosisabhängig Morbidität und Letalität und haben möglicherweise Einfluss auf den Verlauf von Krebserkrankungen.

  • Durch Schonung und Stärkung patienteneigener Ressourcen können Situationen umgangen werden, in denen Bluttransfusionen notwendig werden.

  • Blutprodukte sind Medikamente mit relevantem Nebenwirkungsspektrum, die leitliniengerecht angewandt werden müssen.

  • Die interdisziplinäre Optimierung perioperativer Prozesse erhöht die Qualität der Patientenversorgung und hat das Potenzial, Komplikationsraten und Letalität nachhaltig zu senken.

  • Die Steigerung der Patientensicherheit durch Verbesserung der Heilungsverläufe ist das Ziele des Patient Blood Managements!

  • Jeder oben genannte Baustein kann einen wichtigen Beitrag leisten, doch summativ hat das vorgeschlagene Maßnahmenbündel den größten Effekt.

Schlüsselwörter:

Patient Blood Management - blood alternatives - Patientensicherheit - Versorgungsforschung - krankenhauserworbene Anämie

Key words:

patient blood management - blood alternatives - patient safety - health services research - hospital-acquired anaemia

Ergänzendes Material

 

  • Literaturverzeichnis

  • 1 Wang Y, Eldridge N, Metersky M et al. National trends in patient safety for four common conditions, 2005–2011. N Engl J Med 2014; 370: 341-351
    CrossrefPubMedGoogle Scholar
  • 2 Koch CG, Li L, Sun Z et al. Hospital-acquired anemia: Prevalence, outcomes, and healthcare implications. J Hosp Med 2013; 8: 506-512
    CrossrefPubMedGoogle Scholar
  • 3 Schlitt A, Jambor C, Spannagl M et al. The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors. Dt Arztebl Int 2013; 110: 525-532
    PubMedGoogle Scholar
  • 4 Siegal D, Yudin J, Kaatz S et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circ 2012; 126: 1630-1639
    CrossrefPubMedGoogle Scholar
  • 5 Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-2747
    CrossrefPubMedGoogle Scholar
  • 6 Odum LE, Cochran KA, Aistrope DS, Snella KA. The CHADS(2)versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use. Pharmacotherapy 2012; 32: 285-296
    CrossrefPubMedGoogle Scholar
  • 7 Trappe HJ. Atrial fibrillation: established and innovative methods of evaluation and treatment. Dt Arztebl Int 2012; 109: 1-7
    PubMedGoogle Scholar
  • 8 Weber CF, Zacharowski K, Brun K et al. Basisalgorithmus für „Point-of-Care“ basierte Hämotherapie. Der Anaesthesist 2013; 62: 464-472
    CrossrefPubMedGoogle Scholar
  • 9 Schellong SM, Haas S. Perioperative Thromboseprophylaxe – Neue orale Antikoagulanzien und ihre Anwendung im Umfeld operativer Eingriffe. Anasthesiol Intensivmed Notfallmed Schmerzther 2012; 47: 266-272
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Angiolillo DJ, Firstenberg MS, Price MJ et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 2012; 307: 265-274
    CrossrefPubMedGoogle Scholar
  • 11 Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009; 30: 2769-2812
    CrossrefPubMedGoogle Scholar
  • 12 Bechstein WO, Strey C. Möglichkeiten der lokalen und systemischen Blutstillung bei chirurgischen Eingriffen. Der Chirurg 2007; 78: 95-100
    CrossrefPubMedGoogle Scholar
  • 13 Choi WS, Samman N. Risks and benefits of deliberate hypotension in anaesthesia: a systematic review. Int J Oral Maxillofac Surg 2008; 37: 687-703
    CrossrefPubMedGoogle Scholar
  • 14 Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010; 105: 401-416
    CrossrefPubMedGoogle Scholar
  • 15 Bundesärztekammer Hrsg. Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 4. Aufl. Köln: Deutscher Ärzte-Verlag; 2009
    Google Scholar
  • 16 Pape A, Kertscho H, Stein P et al. Neuromuscular blockade with rocuronium bromide increases the tolerance of acute normovolemic anemia in anesthetized pigs. European Surgical Research 2012; 48: 16-25
    CrossrefPubMedGoogle Scholar
  • 17 Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009; 37 (Suppl. 07) 186-202
    CrossrefPubMedGoogle Scholar
  • 18 S3-Leitlinie "Vermeidung von ungeplanter perioperativer Hypothermie". http://www.awmf.org/leitlinien/detail/anmeldung/1/ll/001-018.html
    PubMedGoogle Scholar
  • 19 Dietrich W, Faraoni D, von Heymann C et al. ESA guidelines on the management of severe perioperative bleeding: Comments on behalf of the Subcommittee on Transfusion and Haemostasis of the European Association of Cardiothoracic Anaesthesiologists. Eur J Anaesthesiol 2014; 31: 239-41
    PubMedGoogle Scholar
  • 20 Weber CF, Gorlinger K, Meininger D et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-547
    CrossrefPubMedGoogle Scholar
  • 21 Bollinger DTK. Roles of Thrombelastography and Thromboelastometry for Patient Blood Management in Cardiac Surgery. Transf Med Rev 2013; 27: 213-220
    CrossrefPubMedGoogle Scholar
  • 22 CRASH-2 trial collaborators. Shakur H, Roberts I, Bautista R et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32
    CrossrefPubMedGoogle Scholar
  • 23 http://www.ains24.de/haemostase/downloads/bleedcard.pdf
    PubMed
  • 24 Statistische Bundesamt. Verbrauch von Blutprodukten durch Transfusionen. http://www.gbe-bund.de
    PubMedGoogle Scholar
  • 25 Hourfar MK, Jork C, Schottstedt V et al. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008; 48: 1558-1566
    CrossrefPubMedGoogle Scholar
  • 26 Vamvakas EC. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice. Transfusion 2013; 53: 888-901
    CrossrefPubMedGoogle Scholar
  • 27 Ferraris VA, Davenport DL, Saha SP et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147: 49-55
    CrossrefPubMedGoogle Scholar
  • 28 Lee JS, Gladwin MT. Bad blood: the risks of red cell storage. Nat Med 2010; 16: 381-382
    CrossrefPubMedGoogle Scholar
  • 29 Cata JP, Wang H, Gottumukkala V et al. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013; 110: 690-701
    CrossrefPubMedGoogle Scholar
  • 30 Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 2012; 256: 235-244
    CrossrefPubMedGoogle Scholar
  • 31 Loor G, Rajeswaran J, Li L et al. The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both?. J Thorac Cardiovasc Surg 2013; 146
    PubMedGoogle Scholar
  • 32 Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev CD 002042 2012; 4
    PubMedGoogle Scholar
  • 33 Hamm CW, Bassand JP, Agewall S et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054
    CrossrefPubMedGoogle Scholar
  • 34 Nguyen BV, Bota DP, Melot C, Vincent JL. Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 2003; 31: 406-410
    CrossrefPubMedGoogle Scholar
  • 35 Harber CR, Sosnowski KJ, Hegde RM. Highly conservative phlebotomy in adult intensive care – a prospective randomized controlled trial. Anaesth Intensive Care 2006; 34: 434-437
    PubMedGoogle Scholar
  • 36 Sanchez-Giron F, Alvarez-Mora F. Reduction of blood loss from laboratory testing in hospitalized adult patients using small-volume (pediatric) tubes. Arch Pathol Lab Med 2008; 132: 1916-1919
    PubMedGoogle Scholar
  • 37 Frasca D, Dahyot-Fizelier C, Catherine K et al. Accuracy of a continuous noninvasive hemoglobin monitor in intensive care unit patients. Crit Care Med 2011; 39: 2277-2282
    CrossrefPubMedGoogle Scholar
  • 38 O'Reilly M. Understanding noninvasive and continuous hemoglobin monitoring. Crit Care Med 2013; 41
    PubMedGoogle Scholar
  • 39 National Blood Authority, Australia. Patient blood management guidelines. http://www.nba.gov.au/guidelines/review.html
    PubMedGoogle Scholar